Oncimmune Holdings plc

ONC.L

ONC.LOncimmune Holdings plc GB flag

London Stock Exchange

1.14

GBp

-0.05

(-4.20%)

-0.05EPS

-0.23P/E

1.27MMarket Cap

May 19Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

GB00BYQ94H38

CUSIP

G6750T108

Return %

Stock

S&P500

-88.94

18.57

-97.87

40.07

-95.56

86.07

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	- -	0.03	0.02	0.03	0.01	- -	- -	- -	0.01	0.06	0.05	0.02
Basic EPS, GAAP	- -	-0.06	-0.03	-0.04	-0.24	-0.1	-0.11	-0.13	-0.13	-0.08	-0.14	0.06
Free Cash Flow per Basic Share	- -	-0.06	-0.04	-0.03	-0.09	-0.09	-0.12	-0.12	-0.14	-0.09	-0.1	-0.09
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	-0.59	-0.62	-0.66	-1.04	-0.83	-0.88	-0.92	-1.02	-1.01	-1.14	-0.59
Tangible Book Value per Share	- -	-0.01	-0.04	-0.08	0.27	0.09	0.23	0.08	-0.05	-0.01	-0.11	-0.02
Basic Weighted Avg Shares	- -	51	51	51	36	51	56	62	63	65	69	73
Sales/Revenue/Turnover	- -	2	1	1	- -	- -	- -	- -	1	4	3	1
Operating Margin (%)	- -	-201.43	-260.64	-102.68	-1,328.84	-2,452.56	-2,655.83	-5,022.81	-1,941.65	-140.17	-267.81	-379.17
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Net Income, GAAP	- -	-3	-1	-2	-8	-5	-6	-8	-8	-5	-10	4
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	-196.48	-133.59	-149.59	-1,963.26	-2,336.28	-2,642.5	-4,685.38	-1,661.89	-134.12	-296.69	356.25
Working Capital	2	-1	1	- -	10	4	13	5	3	6	-5	4
LT Debt	1	- -	3	4	- -	- -	- -	- -	7	7	3	5
Total Equity	1	- -	-2	-4	10	5	14	8	- -	5	-3	1
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	61.19%	144.44%	-64.07%
Net Income, GAAP	23.3%	-12.34%	-143.15%
Free Cash Flow	15.47%	4.31%	1.59%
Total Cash Common Dividend	- -	- -	- -
Total Equity	-292.8%	-643.01%	-124.09%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Martin John Gouldstone
Full Time Employees: 38
Sector: Healthcare
Industry: Biotechnology
Address: MediCity Nottingham United Kingdom NG90 6BH
IPO Date: May 18, 2016
Website: oncimmune.com
Similar Companies: Braxia Scientific Corp. (BRAX.CN)
Ribomic Inc. (4591.T)
Akebia Therapeutics, Inc. (AKBA)
Humanigen, Inc. (HGENQ)
Lexston Life Sciences Corp. (LEXTF)
Atrys Health, S.A. (ATRY.MC)
Business: Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	- -	0.03	0.02	0.03	0.01	- -	- -	- -	0.01	0.06	0.05	0.02
Basic EPS, GAAP	- -	-0.06	-0.03	-0.04	-0.24	-0.1	-0.11	-0.13	-0.13	-0.08	-0.14	0.06
Free Cash Flow per Basic Share	- -	-0.06	-0.04	-0.03	-0.09	-0.09	-0.12	-0.12	-0.14	-0.09	-0.1	-0.09
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	-0.59	-0.62	-0.66	-1.04	-0.83	-0.88	-0.92	-1.02	-1.01	-1.14	-0.59
Tangible Book Value per Share	- -	-0.01	-0.04	-0.08	0.27	0.09	0.23	0.08	-0.05	-0.01	-0.11	-0.02
Basic Weighted Avg Shares	- -	51	51	51	36	51	56	62	63	65	69	73
Sales/Revenue/Turnover	- -	2	1	1	- -	- -	- -	- -	1	4	3	1
Operating Margin (%)	- -	-201.43	-260.64	-102.68	-1,328.84	-2,452.56	-2,655.83	-5,022.81	-1,941.65	-140.17	-267.81	-379.17
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Net Income, GAAP	- -	-3	-1	-2	-8	-5	-6	-8	-8	-5	-10	4
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	-196.48	-133.59	-149.59	-1,963.26	-2,336.28	-2,642.5	-4,685.38	-1,661.89	-134.12	-296.69	356.25
Working Capital	2	-1	1	- -	10	4	13	5	3	6	-5	4
LT Debt	1	- -	3	4	- -	- -	- -	- -	7	7	3	5
Total Equity	1	- -	-2	-4	10	5	14	8	- -	5	-3	1
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Oncimmune Holdings plc

Growth Rates

(avg. rate of change)

Company Description

Capital Structure

Working Capital

Growth Rates

(avg. rate of change)

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Year	Q1	Q2	Q3	Q4	FY
2021	- -	- -	- -	- -	-0.08
2022	- -	- -	- -	- -	-0.14
2023	- -	- -	- -	- -	0.06